Michael Oberst

Person

Gaithersburg, MD, US

People

Patents Grantslast 30 patents

Information Patent Grant
Bispecific binding proteins and uses thereof
- Patent number RE49908
- Issue date Apr 9, 2024
- MedImmune, LLC
- Srinath Kasturirangan
Information Patent Grant
Bispecific binding proteins and uses thereof
- Patent number 11,279,759
- Issue date Mar 22, 2022
- MedImmune, LLC
- Srinath Kasturirangan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bispecific binding proteins and uses thereof
- Patent number 10,457,732
- Issue date Oct 29, 2019
- MedImmune, LLC
- Srinath Kasturirangan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method of treating cancer with humanized anti-OX40 antibodies
- Patent number 10,150,815
- Issue date Dec 11, 2018
- MedImmune, LLC
- Scott A. Hammond
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Humanized anti-OX40 antibodies and uses thereof
- Patent number 9,738,723
- Issue date Aug 22, 2017
- MedImmune, LLC
- Scott A. Hammond
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
OX40L fusion proteins and uses thereof
- Patent number 9,718,870
- Issue date Aug 1, 2017
- MedImmune, LLC
- Melissa Damschroder
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
BISPECIFIC BINDING PROTEINS AND USES THEREOF
- Publication number 20220251204
- Publication date Aug 11, 2022
- Medimmune, LLC
- SRINATH KASTURIRANGAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BISPECIFIC BINDING PROTEINS AND USES THEREOF
- Publication number 20200172622
- Publication date Jun 4, 2020
- Medimmune, LLC
- SRINATH KASTURIRANGAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BISPECIFIC FUSION POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20190241659
- Publication date Aug 8, 2019
- Medimmune, LLC
- JOHN MUMM
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Humanized Anti-OX40 Antibodies and Uses Thereof
- Publication number 20190169303
- Publication date Jun 6, 2019
- Medimmune, LLC
- SCOTT A. HAMMOND
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMANIZED ANTI-OX40 ANTIBODIES AND USES THEREOF
- Publication number 20180072808
- Publication date Mar 15, 2018
- Medimmune, LLC
- SCOTT A. HAMMOND
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC BINDING PROTEINS AND USES THEREOF
- Publication number 20180022807
- Publication date Jan 25, 2018
- Medimmune, LLC
- Srinath KASTURIRANGAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
THERAPEUTIC COMBINATIONS AND METHODS FOR TREATING NEOPLASIA
- Publication number 20160347848
- Publication date Dec 1, 2016
- MEDIMMUNE LIMITED
- Scott A. HAMMOND
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HUMANIZED ANTI-OX40 ANTIBODIES AND USES THEREOF
- Publication number 20160137740
- Publication date May 19, 2016
- Medimmune, LLC
- SCOTT A. HAMMOND
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OX40L FUSION PROTEINS AND USES THEREOF
- Publication number 20160024176
- Publication date Jan 28, 2016
- Medimmune, LLC
- Melissa Damschroder
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS AND COMPOSITIONS FOR DETECTING AND TREATING CEA-EXPRESSING...
- Publication number 20130035249
- Publication date Feb 7, 2013
- Medimmune, LLC
- Scott Hammond
- G01 - MEASURING TESTING
Information Patent Application
Activation of matriptase and diagnostic and therapeutic methods bas...
- Publication number 20030170245
- Publication date Sep 11, 2003
- Robert B. Dickson
- C07 - ORGANIC CHEMISTRY

Michael Oberst

Person

Patents Grantslast 30 patents

Bispecific binding proteins and uses thereof

Bispecific binding proteins and uses thereof

Bispecific binding proteins and uses thereof

Method of treating cancer with humanized anti-OX40 antibodies

Humanized anti-OX40 antibodies and uses thereof

OX40L fusion proteins and uses thereof

Patents Applicationslast 30 patents

BISPECIFIC BINDING PROTEINS AND USES THEREOF

BISPECIFIC BINDING PROTEINS AND USES THEREOF

BISPECIFIC FUSION POLYPEPTIDES AND METHODS OF USE THEREOF

Humanized Anti-OX40 Antibodies and Uses Thereof

HUMANIZED ANTI-OX40 ANTIBODIES AND USES THEREOF

BISPECIFIC BINDING PROTEINS AND USES THEREOF

THERAPEUTIC COMBINATIONS AND METHODS FOR TREATING NEOPLASIA

HUMANIZED ANTI-OX40 ANTIBODIES AND USES THEREOF

OX40L FUSION PROTEINS AND USES THEREOF

METHODS AND COMPOSITIONS FOR DETECTING AND TREATING CEA-EXPRESSING...

Activation of matriptase and diagnostic and therapeutic methods bas...